Neue Entwicklungen in der Demenzdiagnostik und -behandlung

摘要: New Developments in Diagnosis and Treatment of Dementia. diagnostic research criteria were established 2007. In the past 8 years International Working Group (IWG) NIA have contributed for diagnosis AD that better define clinical phenotypes integrate biomarkers into staging process, covering full disease. The newest DSM-5 introduces several changes dementia other cognitive disorders. Cognitive disorders do not cause sufficient impairment to qualify a are now defined as minor neurocognitive placed on spectrum with more severe conditions (major). Recently developed amyloid-PET-tracers useful und efficient tools depict earliest stages AD. F18tracers longer half-life 110 minutes may also serve directly monitor amyloid load due new treatment approaches. Dopamine transporter loss has proven reliably differentiate Lewy-bodies from dementias I-FP-CIT-SPECT remains “gold standard” imaging DLB. concept dietetic intervention drawn increasing attention. medical foods strictly intended therapeutic purposes first scientific studies Acutil® Souvenaid® show promising results very benign side effect profile. J Neurol Neurochir Psychiatr 2015; 16 (3): 111–8.